← Archive

The 39 Percent Problem: Children's Hospitals Are Running on a Medicaid Subsidy That CMS Just Proposed to Cap

State directed payments account for 39% of children's hospitals' Medicaid funding and 15% of their overall operating resources. CMS's proposed cap is not peripheral to pediatric Medicaid financing. It is central to it.

Pediatric Health Dispatch — Deep Dispatch | June 4, 2026

What the New Coverage Floor Costs

CMS has had a productive spring for pediatric coverage policy. In March, the agency announced ASPIRE, a ten-year federal model committing $125 million to support up to five states in building whole-person care infrastructure for Medicaid and CHIP children with complex medical and behavioral needs. In May, the agency released an updated EPSDT Coverage Guide clarifying the federal floor for children's services, including a directive that states cannot impose hard limits on the amount, duration, or scope of medically necessary behavioral-health and telehealth services. Also in May, CMS opened public comment on new quality measures for children receiving Medicaid-funded home and community-based services. Each of these actions extends what Medicaid formally promises to children.

On May 20, CMS also proposed something else. A rule capping state directed payments in Medicaid managed care at 100% of Medicare rates in expansion states and 110% in non-expansion states, with similar limits on targeted fee-for-service practitioner payments. The agency estimates $775 billion in ten-year savings. That second announcement is the one pediatric leaders and investors should be reading carefully.

State directed payments are not a technical footnote. They are the mechanism states use to route enhanced Medicaid dollars to hospitals and provider networks above baseline rates, and they have grown into the dominant payment-enhancement tool in the Medicaid managed care system. CMS's own impact analysis says SDPs reached $143.8 billion in fiscal year 2025, equal to 14% of all Medicaid benefit spending and 26% of all Medicaid managed care payments. The agency notes that 87.5% of those dollars go to hospitals.

For children's hospitals specifically, the Children's Hospital Association puts the stakes plainly: state directed payments account for 39% of children's hospitals' Medicaid funding and 15% of their overall operating resources. That means for every dollar these hospitals generate in total revenue, roughly 15 cents flows through a payment mechanism the new rule would cap. The underlying math is already unfavorable before the cap arrives. Medicaid pays an average of 88 cents on the dollar for hospital care. State directed payments close part of that gap for some hospitals, by an estimated 20% according to CHA, but they do not close it entirely. Constrain the tool, and hospitals already running below cost on Medicaid face a second round of compression.

The timing is what makes this analytically interesting. CMS is proposing to cap the financing mechanism at the exact moment it is expanding the coverage obligations. EPSDT says children must receive any medically necessary service without hard utilization limits. ASPIRE invites states to build pediatric complex-care infrastructure. Pediatric HCBS quality measures signal that home-and-community care for children with disabilities should meet higher performance standards. All of those mandates require providers to deliver more, coordinate better, and document outcomes. All of them rely on an ecosystem of children's hospitals, pediatric networks, and Medicaid-facing providers that currently depend on directed-payment enhancements to stay financially viable.

The framing in most coverage is that this is a budget-savings rule. It is. It is also a structural repricing of how much states can afford to pay the providers who carry out those newly expanded federal mandates.

The Benchmark That Doesn't Exist

The proposed rule caps new state directed payments at 100% of what Medicare would pay for the same service. That sounds like a principled benchmark until you ask a question the rule does not cleanly answer: what Medicare rate applies to services that Medicare barely reimburses, or does not cover at all?

Medicare is a program for adults over 65 and certain disabled adults. Its rate-setting does not center on pediatric care, and it does not cover many services that children with complex medical needs routinely receive. Pediatric palliative care consultations, developmental pediatrics evaluations, early-intervention services delivered in home settings, school-based health, and high-intensity private-duty nursing for technology-dependent children do not map cleanly onto a Medicare fee schedule. For services without a specified total published Medicare payment rate, the proposed rule's fallback benchmark is the Medicaid state plan rate, not a pediatric-adjusted Medicare equivalent.

Georgetown's Center for Children and Families flagged this directly: under the rule as written, the fallback mechanism would effectively eliminate or sharply constrain directed payments for many pediatric, maternal, and home-and-community-based services that cannot be pegged to a Medicare rate. For children's hospitals, that is not a narrow edge case. It is a significant portion of their Medicaid-funded clinical volume.

The gap shows up in named examples. In Illinois, Lurie Children's All Hands Health Network holds a CMS-approved Medicaid managed care value-based payment SDP for eligible primary care providers, active through the end of 2026. That arrangement is pediatric VBC infrastructure already sitting inside the directed-payment machinery, the exact kind of model ASPIRE is designed to scale nationally. In New Hampshire, a hospital directed-payment preprint names Boston Children's Hospital explicitly and models the add-on at 99.8% of the state's actuarial cost-to-charge benchmark. In Virginia, physicians at the Children's Hospital of The King's Daughters are covered through a freestanding children's-hospital physician SDP flowing through Cardinal Care managed-care plans. These are not theoretical exposures. They are existing, CMS-approved directed-payment arrangements for specific pediatric facilities that would need to be redesigned under the cap.

The OBBBA context makes the picture more complex. That legislation, signed July 2025 with provisions taking effect through 2027, attacks the same financing stack from a different direction: reduced federal matching, provider-tax restrictions, and eligibility churn that narrows the Medicaid enrollment base. The SDP cap attacks a different layer: the payment-enhancement mechanism states use to route managed care dollars to providers above standard actuarial rates. One policy narrows state fiscal room. The other narrows the state's ability to route enhanced payments through the tools that remain. For children's hospitals where CHA says SDPs equal 39% of Medicaid funding, those pressures are not simply additive. They compound each other on a financial base that was already thin.

Provider-sponsored pediatric health plans sit in structurally similar territory through a different channel. Texas Children's Health Plan covers more than 600,000 members across 50-plus Texas counties through STAR, CHIP, and STAR Kids. Partners For Kids holds full-risk capitation for more than 470,000 children across 47 Ohio counties, in a managed-care environment where the state's directed-payment pool reached $116 million for the most recent approved period. These entities are not direct SDP recipients in the same way a hospital billing for services is. But SDP dollars flow through the actuarial rate certifications and managed-care contracts that determine how much plans get paid. When the enhancement mechanism shrinks, the payment environment those entities operate inside gets tighter.

Who Absorbs the Gap

The question the rule creates is not rhetorical: if state directed payments to children's hospitals and pediatric provider networks get constrained, someone absorbs the gap. The exposure is not equally distributed.

Children's hospitals carry the most direct and documentable risk. They cannot reroute their Medicaid patient panels to higher-margin payers or redesign their clinical programs around the benchmark gap on a short timeline. The range of responses available includes cross-subsidizing from commercial margins (which are also under pressure), service-line consolidation, or renegotiating managed-care contracts in an environment where state actuarial capacity is also constrained. None of those adjustments are fast, and all of them have downstream effects on the broader pediatric provider ecosystem.

Provider-sponsored pediatric plans face a different version of the same problem. If the SDP dollars flowing into their actuarial rate certifications shrink, the plan either absorbs the margin reduction, renegotiates network payments, or reduces the care-management investment that distinguishes it from a straight pass-through MCO. For plans like Texas Children's and Cook Children's Health Plan that were built specifically to hold pediatric risk in Medicaid, the operating model depends on that care-management investment remaining viable.

For startups, the exposure is indirect but structural. Companies like Imagine Pediatrics, which contracts with Medicaid managed-care plans to provide 24/7 complex-care support for children with special health care needs, build their unit economics on capitation arrangements that depend on a functioning payer ecosystem. If the plans they contract with are facing tighter actuarial rates, the procurement environment tightens. If children's hospitals are reducing operating costs to offset compressed SDPs, the partnership and referral relationships that support patient flow into high-touch care models get smaller margins to absorb them.

There is a partial offset embedded in the rule's design. Value-based payment arrangements can qualify for different treatment under the proposed framework, and the Lurie Children's VBP-linked SDP demonstrates that outcome-linked pediatric VBC infrastructure is already flowing through this mechanism. If CMS either carves out VBP-linked SDPs from the cap or establishes a pediatric-specific benchmark exception, entities that have built measurable outcome frameworks get a structural advantage over volume-based counterparts. That logic is the same market-design signal embedded in ASPIRE: outcome documentation creates defensible payment structures in an environment where the financing baseline is tightening.

The timeline is not abstract. Comments on the proposed rule close July 21, 2026. The Children's Hospital Association has already filed a formal response. Georgetown CCF has explicitly warned that finalizing the rule as written may invite legal challenge. If the rule moves to finalization on the current trajectory, grandfathered SDPs begin phasing down January 1, 2028. Any organization underwriting a children's hospital partnership, a provider-sponsored pediatric plan, or a Medicaid-facing startup with a multi-year horizon is already operating inside the exposure window.

CMS has, in the span of roughly 90 days, raised the federal coverage floor for children on multiple fronts and proposed capping the primary mechanism states use to pay the providers responsible for meeting it. Those two moves are not contradictory from a federal budget standpoint. For the children's hospitals, pediatric plans, and startups that must operate inside both simultaneously, the math is getting materially harder.

---

---